ChloroquineV1, Main, Exploration, bibRecord, 002E16

Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs

Identifieur interne : 002E16 ( Main/Exploration ); précédent : 002E15; suivant : 002E17

Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs

Auteurs : O. Scherak [Autriche] ; W. Popp ; G. Kolarz ; A. Wottawa ; L. Ritschka ; O. Braun

Source :

Journal of rheumatology [ 0315-162X ] ; 1993.

RBID : Pascal:93-0499834

Descripteurs français

KwdFr :
- Adulte d'âge moyen, Anti-inflammatoires (usage thérapeutique), Antirhumatismaux (usage thérapeutique), Biopsie, Chloroquine (usage thérapeutique), Composés organiques de l'or, Humains, Liquide de lavage bronchoalvéolaire (anatomopathologie), Méthotrexate (usage thérapeutique), Polyarthrite rhumatoïde (anatomopathologie), Polyarthrite rhumatoïde (traitement médicamenteux), Poumon (anatomopathologie), Pénicillamine (usage thérapeutique), Sous-populations de lymphocytes (anatomopathologie), Sujet âgé.
MESH :
- anatomopathologie : Liquide de lavage bronchoalvéolaire, Polyarthrite rhumatoïde, Poumon, Sous-populations de lymphocytes.
- traitement médicamenteux : Polyarthrite rhumatoïde.
- usage thérapeutique : Anti-inflammatoires, Antirhumatismaux, Chloroquine, Méthotrexate, Pénicillamine.
Pascal (Inist)
- Adulte d'âge moyen, Biopsie, Composés organiques de l'or, Humains, Polyarthrite rhumatoïde, Antirhumatismal, Adulte, Chimiothérapie, Chronique, Sujet âgé, Traitement, Etude comparative, Exploration, Cytologie, Leucocyte.
Wicri :
- topic : Adulte, Cytologie.

English descriptors

KwdEn :
- Adult, Aged, Anti-Inflammatory Agents (therapeutic use), Antirheumatic Agents (therapeutic use), Antirheumatic agent, Arthritis, Rheumatoid (drug therapy), Arthritis, Rheumatoid (pathology), Biopsy, Bronchoalveolar Lavage Fluid (pathology), Chemotherapy, Chloroquine (therapeutic use), Chronic, Comparative study, Cytology, Exploration, Humans, Leukocyte, Lung (pathology), Lymphocyte Subsets (pathology), Methotrexate (therapeutic use), Middle Aged, Organogold Compounds, Penicillamine (therapeutic use), Rheumatoid arthritis, Treatment.
MESH :
- chemical , therapeutic use : Anti-Inflammatory Agents, Antirheumatic Agents, Chloroquine, Methotrexate, Penicillamine.
- drug therapy : Arthritis, Rheumatoid.
- pathology : Arthritis, Rheumatoid, Bronchoalveolar Lavage Fluid, Lung, Lymphocyte Subsets.
- Aged, Biopsy, Humans, Middle Aged, Organogold Compounds.

Abstract

Bronchoalveolar lavage (BAL) and histology of transbronchial forceps biopsy was performed in 59 patients with rheumatoid arthritis (RA) to evaluate the in vivo effects of disease modifying drugs (DMARD). All patients had no clinical pulmonary symptoms and there was no evidence of drug induced alveolitis. Patients were divided into 5 subgroups according to drug treatment: 9 patients taking chloroquine, 15 patients gold, 8 patients penicillamine, 8 patients methotrexate (MTX) and 19 patients not taking DMARD. Duration of DMARD regimen was more than 3 months. No patient was treated with corticosteroids

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs</title>
<author><name sortKey="Scherak, O" sort="Scherak, O" uniqKey="Scherak O" first="O." last="Scherak">O. Scherak</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Univ. Wien, Pathologisch-Anatomisches Inst.</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
</inist:fA14>
<country>Autriche</country>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Popp, W" sort="Popp, W" uniqKey="Popp W" first="W." last="Popp">W. Popp</name>
</author>
<author><name sortKey="Kolarz, G" sort="Kolarz, G" uniqKey="Kolarz G" first="G." last="Kolarz">G. Kolarz</name>
</author>
<author><name sortKey="Wottawa, A" sort="Wottawa, A" uniqKey="Wottawa A" first="A." last="Wottawa">A. Wottawa</name>
</author>
<author><name sortKey="Ritschka, L" sort="Ritschka, L" uniqKey="Ritschka L" first="L." last="Ritschka">L. Ritschka</name>
</author>
<author><name sortKey="Braun, O" sort="Braun, O" uniqKey="Braun O" first="O." last="Braun">O. Braun</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">93-0499834</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 93-0499834 INIST</idno>
<idno type="RBID">Pascal:93-0499834</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000097</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000073</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000097</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000097</idno>
<idno type="wicri:doubleKey">0315-162X:1993:Scherak O:bronchoalveolar:lavage:and</idno>
<idno type="wicri:Area/Main/Merge">002E81</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8102405</idno>
<idno type="wicri:Area/PubMed/Corpus">000538</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000538</idno>
<idno type="wicri:Area/PubMed/Curation">000538</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000538</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000514</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000514</idno>
<idno type="wicri:Area/Ncbi/Merge">001152</idno>
<idno type="wicri:Area/Ncbi/Curation">001152</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001152</idno>
<idno type="wicri:doubleKey">0315-162X:1993:Scherak O:bronchoalveolar:lavage:and</idno>
<idno type="wicri:Area/Main/Merge">002D79</idno>
<idno type="wicri:Area/Main/Curation">002E16</idno>
<idno type="wicri:Area/Main/Exploration">002E16</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs</title>
<author><name sortKey="Scherak, O" sort="Scherak, O" uniqKey="Scherak O" first="O." last="Scherak">O. Scherak</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Univ. Wien, Pathologisch-Anatomisches Inst.</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
</inist:fA14>
<country>Autriche</country>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Popp, W" sort="Popp, W" uniqKey="Popp W" first="W." last="Popp">W. Popp</name>
</author>
<author><name sortKey="Kolarz, G" sort="Kolarz, G" uniqKey="Kolarz G" first="G." last="Kolarz">G. Kolarz</name>
</author>
<author><name sortKey="Wottawa, A" sort="Wottawa, A" uniqKey="Wottawa A" first="A." last="Wottawa">A. Wottawa</name>
</author>
<author><name sortKey="Ritschka, L" sort="Ritschka, L" uniqKey="Ritschka L" first="L." last="Ritschka">L. Ritschka</name>
</author>
<author><name sortKey="Braun, O" sort="Braun, O" uniqKey="Braun O" first="O." last="Braun">O. Braun</name>
</author>
</analytic>
<series><title level="j" type="main">Journal of rheumatology</title>
<title level="j" type="abbreviated">J. rheumatol.</title>
<idno type="ISSN">0315-162X</idno>
<imprint><date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of rheumatology</title>
<title level="j" type="abbreviated">J. rheumatol.</title>
<idno type="ISSN">0315-162X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Anti-Inflammatory Agents (therapeutic use)</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Antirheumatic agent</term>
<term>Arthritis, Rheumatoid (drug therapy)</term>
<term>Arthritis, Rheumatoid (pathology)</term>
<term>Biopsy</term>
<term>Bronchoalveolar Lavage Fluid (pathology)</term>
<term>Chemotherapy</term>
<term>Chloroquine (therapeutic use)</term>
<term>Chronic</term>
<term>Comparative study</term>
<term>Cytology</term>
<term>Exploration</term>
<term>Humans</term>
<term>Leukocyte</term>
<term>Lung (pathology)</term>
<term>Lymphocyte Subsets (pathology)</term>
<term>Methotrexate (therapeutic use)</term>
<term>Middle Aged</term>
<term>Organogold Compounds</term>
<term>Penicillamine (therapeutic use)</term>
<term>Rheumatoid arthritis</term>
<term>Treatment</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Anti-inflammatoires (usage thérapeutique)</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Biopsie</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Composés organiques de l'or</term>
<term>Humains</term>
<term>Liquide de lavage bronchoalvéolaire (anatomopathologie)</term>
<term>Méthotrexate (usage thérapeutique)</term>
<term>Polyarthrite rhumatoïde (anatomopathologie)</term>
<term>Polyarthrite rhumatoïde (traitement médicamenteux)</term>
<term>Poumon (anatomopathologie)</term>
<term>Pénicillamine (usage thérapeutique)</term>
<term>Sous-populations de lymphocytes (anatomopathologie)</term>
<term>Sujet âgé</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term>
<term>Antirheumatic Agents</term>
<term>Chloroquine</term>
<term>Methotrexate</term>
<term>Penicillamine</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Liquide de lavage bronchoalvéolaire</term>
<term>Polyarthrite rhumatoïde</term>
<term>Poumon</term>
<term>Sous-populations de lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Rheumatoid</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arthritis, Rheumatoid</term>
<term>Bronchoalveolar Lavage Fluid</term>
<term>Lung</term>
<term>Lymphocyte Subsets</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Polyarthrite rhumatoïde</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires</term>
<term>Antirhumatismaux</term>
<term>Chloroquine</term>
<term>Méthotrexate</term>
<term>Pénicillamine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Biopsy</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Organogold Compounds</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Biopsie</term>
<term>Composés organiques de l'or</term>
<term>Humains</term>
<term>Polyarthrite rhumatoïde</term>
<term>Antirhumatismal</term>
<term>Adulte</term>
<term>Chimiothérapie</term>
<term>Chronique</term>
<term>Sujet âgé</term>
<term>Traitement</term>
<term>Etude comparative</term>
<term>Exploration</term>
<term>Cytologie</term>
<term>Leucocyte</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
<term>Cytologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Bronchoalveolar lavage (BAL) and histology of transbronchial forceps biopsy was performed in 59 patients with rheumatoid arthritis (RA) to evaluate the in vivo effects of disease modifying drugs (DMARD). All patients had no clinical pulmonary symptoms and there was no evidence of drug induced alveolitis. Patients were divided into 5 subgroups according to drug treatment: 9 patients taking chloroquine, 15 patients gold, 8 patients penicillamine, 8 patients methotrexate (MTX) and 19 patients not taking DMARD. Duration of DMARD regimen was more than 3 months. No patient was treated with corticosteroids</div>
</front>
</TEI>
<affiliations><list><country><li>Autriche</li>
</country>
<region><li>Vienne (Autriche)</li>
</region>
<settlement><li>Vienne (Autriche)</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Braun, O" sort="Braun, O" uniqKey="Braun O" first="O." last="Braun">O. Braun</name>
<name sortKey="Kolarz, G" sort="Kolarz, G" uniqKey="Kolarz G" first="G." last="Kolarz">G. Kolarz</name>
<name sortKey="Popp, W" sort="Popp, W" uniqKey="Popp W" first="W." last="Popp">W. Popp</name>
<name sortKey="Ritschka, L" sort="Ritschka, L" uniqKey="Ritschka L" first="L." last="Ritschka">L. Ritschka</name>
<name sortKey="Wottawa, A" sort="Wottawa, A" uniqKey="Wottawa A" first="A." last="Wottawa">A. Wottawa</name>
</noCountry>
<country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Scherak, O" sort="Scherak, O" uniqKey="Scherak O" first="O." last="Scherak">O. Scherak</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E16 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002E16 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:93-0499834
   |texte=   Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

Serveur d'exploration Chloroquine

Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs

Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.